We are live on ! Find out more
TCM

Texan Capital Management Portfolio holdings

AUM $154M
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+2.76%
1 Year Est. Return
+10.82%
3 Year Est. Return
+19.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$214M
AUM Growth
+$1.85M
Cap. Flow
-$2.42M
Cap. Flow %
-1.13%
Top 10 Hldgs %
25.62%
Holding
135
New
7
Increased
33
Reduced
52
Closed
5

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$1.18M
2
ABMD
Abiomed Inc
ABMD
+$1.01M
3
IBM icon
IBM
IBM
+$621K
4
SLCA
U.S. SILICA HOLDINGS, INC.
SLCA
+$582K
5
ABBV icon
AbbVie
ABBV
+$499K

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.98M
2
GS icon
Goldman Sachs
GS
+$1.86M
3
CFR icon
Cullen/Frost Bankers
CFR
+$1.39M
4
UA icon
Under Armour Class C
UA
+$1.15M
5
WMT icon
Walmart Inc
WMT
+$517K

Sector Composition

Rank Sector Weight
1 Energy 34.44%
2 Healthcare 11.52%
3 Financials 8.75%
4 Communication Services 8.34%
5 Technology 7.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XOP icon
101
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.78B
$460K 0.22%
2,775
-225
-8% -$35.3K
CLNY
102
DELISTED
Colony Capital, Inc.
CLNY
$454K 0.21%
22,422
– –
APA icon
103
APA Corp
APA
$14.9B
$448K 0.21%
7,064
+500
+8% +$31.5K
AMTG
104
DELISTED
APOLLO RESIDENTIAL MTG INC COM STK
AMTG
$442K 0.21%
32,404
– –
AGNC icon
105
AGNC Investment
AGNC
$12.9B
$431K 0.2%
23,800
– –
SBRA icon
106
Sabra Healthcare REIT
SBRA
$5.29B
$428K 0.2%
17,544
– –
PFE icon
107
Pfizer
PFE
$158B
$424K 0.2%
+13,745
New +$420K
EQM
108
DELISTED
EQM Midstream Partners, LP
EQM
$422K 0.2%
5,500
– –
RWT
109
Redwood Trust
RWT
$578M
$418K 0.2%
27,500
– –
RSPP
110
DELISTED
RSP Permian, Inc.
RSPP
$415K 0.19%
9,300
– –
WLL
111
DELISTED
Whiting Petroleum Corporation
WLL
$362K 0.17%
101
-7
-6% -$21K
WFC icon
112
Wells Fargo
WFC
$260B
$357K 0.17%
6,486
– –
WMT icon
113
Walmart Inc
WMT
$819B
$337K 0.16%
14,643
-22,134
-60% -$517K
OII icon
114
Oceaneering
OII
$5.06B
$302K 0.14%
10,706
– –
BNY
115
Bank of New York Mellon
BNY
$110B
$294K 0.14%
6,209
-737
-11% -$33.2K
CL icon
116
Colgate-Palmolive
CL
$72.3B
$288K 0.13%
4,400
– –
CHRD icon
117
Chord Energy
CHRD
$7.98B
$271K 0.13%
17,925
+4,750
+36% +$61.5K
GL icon
118
Globe Life
GL
$13.5B
$251K 0.12%
3,400
– –
CNP icon
119
CenterPoint Energy
CNP
$25.9B
$219K 0.1%
8,884
– –
ABT icon
120
Abbott
ABT
$195B
$218K 0.1%
+5,671
New +$225K
IOC
121
DELISTED
Interoil Corporation
IOC
$211K 0.1%
4,438
– –
VTLE
122
DELISTED
Vital Energy
VTLE
$154K 0.07%
545
-65
-11% -$17.9K
BBG
123
DELISTED
Bill Barrett Corp
BBG
$147K 0.07%
21,000
– –
NMM icon
124
Navios Maritime Partners
NMM
$2.48B
$144K 0.07%
6,791
– –
ESV
125
DELISTED
Ensco Rowan plc
ESV
$140K 0.07%
3,593
-275
-7% -$9.86K
2 3 4
5
6

Similar funds

WI
Welch Investments Birmingham, Alabama $157M AUM 17.66% 1-Year Est. Return
IA
IPL Advisers New York $158M AUM 18.16% 1-Year Est. Return
W
WealthShield Cary, North Carolina $164M AUM
4IG
440 Investment Group Overland Park, Kansas $140M AUM 17.09% 1-Year Est. Return
AFA
Aurora Financial Advisors Wellesley, Massachusetts $140M AUM
BGC
Blue Granite Capital Charleston, South Carolina $136M AUM 16.44% 1-Year Est. Return
YP
Yellowstone Partners Idaho Falls, Idaho $177M AUM
CCM
CrestPoint Capital Management Four Seasons, Missouri $180M AUM 21.37% 1-Year Est. Return

Texan Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Texan Capital Management held 135 positions worth $214M, up 0.87% from $212M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Texan Capital Management's Q4 2016 filing shows 7 new, 33 increased, 52 reduced and 5 closed positions. Its largest new stake was Abiomed Inc: 8,719 shares worth $982K. The largest sale was Bristol-Myers Squibb, an estimated $1.98M.

By sector, the portfolio is most concentrated in Energy at 34% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.

  • Texan Capital Management's largest Q4 2016 buy was Abiomed Inc: 8,719 shares worth $982K.
  • Texan Capital Management added most to Procter & Gamble in Q4 2016, an estimated $1.18M increase.
  • Texan Capital Management's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $1.98M.
  • Texan Capital Management fully exited Goldman Sachs in Q4 2016, selling an estimated $1.86M.
  • Texan Capital Management's ten largest holdings make up 26% of its $214M portfolio in Q4 2016.
  • Texan Capital Management opened 7 new positions and closed 5 in Q4 2016.
  • Texan Capital Management's portfolio value rose 0.87% quarter-over-quarter to $214M.

Based on Texan Capital Management's 13F filing for Q4 2016, filed 3 Feb 2017.